Title:
神経変性疾患の処置において使用するための治療剤の組み合わせ
Document Type and Number:
Japanese Patent JP2014505722
Kind Code:
A
Abstract:
The present invention relates to a combination of an allosteric mTOR inhibitor and a catalytic mTOR inhibitor for use in the prevention or treatment of neurodegenerative diseases, for example Huntington's Disease, and products and pharmaceutical compositions comprising such a combination for use in the prevention or treatment of such neurodegenerative diseases.
Inventors:
Ivan Garimberti
MURPHY, Leon
MURPHY, Leon
Application Number:
JP2013554038A
Publication Date:
March 06, 2014
Filing Date:
February 14, 2012
Export Citation:
Assignee:
Novartis Age
International Classes:
A61K31/5377; A61K31/436; A61K31/4745; A61P25/00; A61P25/02; A61P25/14; A61P25/16; A61P25/28; A61P43/00
Foreign References:
| WO2010049481A1 | 2010-05-06 |
Other References:
MOL CANCER. 2009 JUN 15;8:38,1-9, JPN6015048110, ISSN: 0003206268
CELL DEATH DIFFER. 2009 JAN;16(1):46-56, JPN6015048108, ISSN: 0003206269
HUM MOL GENET. 2008 JAN 15;17(2):170-8, JPN6015048109, ISSN: 0003206270
CELL DEATH DIFFER. 2009 JAN;16(1):46-56, JPN6015048108, ISSN: 0003206269
HUM MOL GENET. 2008 JAN 15;17(2):170-8, JPN6015048109, ISSN: 0003206270
Attorney, Agent or Firm:
Aoyama Aoi
Takuji Yamada
Michiko Matsutani
Mitsutaka Iwasaki
Sakurai Yoko
Takuji Yamada
Michiko Matsutani
Mitsutaka Iwasaki
Sakurai Yoko